Medizinische Universität Graz - Research portal
Selected Publication:
SHR Neuro Cancer Cardio Lipid Metab Microb
Hoff, KV; Hinkes, B; Gerber, NU; Deinlein, F; Mittler, U; Urban, C; Benesch, M; Warmuth-Metz, M; Soerensen, N; Zwiener, I; Goette, H; Schlegel, PG; Pietsch, T; Kortmann, RD; Kuehl, J; Rutkowski, S.
Long-term outcome and clinical prognostic factors in children with medulloblastoma treated in the prospective randomised multicentre trial HIT'91.
Eur J Cancer. 2009; 45(7): 1209-1217.
Doi: 10.1016/j.ejca.2009.01.015
Web of Science
PubMed
FullText
FullText_MUG
Google Scholar
- Co-authors Med Uni Graz
- Benesch Martin
- Urban Ernst-Christian
- Altmetrics:
- Dimensions Citations:
- Plum Analytics:
- Scite (citation analytics):
- Abstract:
- Purpose: To analyse long-term outcome and clinical prognostic factors in medulloblastoma. Methods: We analysed 280 patients with medulloblastoma (3-18 years) included from 1991 to 1997 in the randomised multicentre trial HIT'91 comparing pre-('sandwich') and postradiation ('maintenance') chemotherapy (median follow-up of survivors for 10 years). Results: In 187 patients with complete staging, overall survival (OS) was higher after maintenance compared to sandwich treatment for MO (10-year OS 91% and 62%, p = 0.001) and M1 patients (10-year OS 70% and 34%, p = 0.020). In M2/3 disease, 10-year OS was 42% and 45%. Incomplete staging, metastases, younger age and sandwich chemotherapy were independent adverse risk factors. Twelve percent of all relapses (13 of 107) occurred after more than five years, and 12 patients had secondary neoplasms. Conclusions: After maintenance therapy, long-term survival was excellent in fully assessable patients with localised medulloblastoma, and favourable for M1 patients. Patients should be followed longer for late relapses and secondary tumours. (C) 2009 Elsevier Ltd. All rights reserved.
- Find related publications in this database (using NLM MeSH Indexing)
- Adolescent -
- Antineoplastic Agents - therapeutic use
- Cerebellar Neoplasms - drug therapy
- Child -
- Child, Preschool -
- Combined Modality Therapy -
- Drug Administration Schedule -
- Female -
- Follow-Up Studies -
- Humans -
- Male -
- Medulloblastoma - drug therapy
- Neoplasm Recurrence, Local -
- Neoplasm Staging -
- Neoplasm, Residual -
- Neoplasms, Second Primary -
- Proportional Hazards Models -
- Survival Rate -
- Treatment Outcome -
- Vincristine - therapeutic use
- Find related publications in this database (Keywords)
- Medulloblastoma
- Children
- Treatment outcome
- Second neoplasm